CUSIP: 60463E103
Q1 2019 13F Holders as of 31 Mar 2019
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
13,240,655
-
Share change
-
-1,423,399
-
Total reported value
-
$36,941,383
-
Price per share
-
$2.79
-
Number of holders
-
49
-
Value change
-
-$4,335,474
-
Number of buys
-
20
-
Number of sells
-
19
Quarterly Holders Quick Answers
What is CUSIP 60463E103?
CUSIP 60463E103 identifies MGEN - MIRAGEN THERAPEUTICS INC - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q2 2019
-
Previous quarter:
Q4 2018
Recent filing periods for CUSIP 60463E103:
Institutional Holders of MIRAGEN THERAPEUTICS INC - COM (MGEN) as of Q1 2019
As of 31 Mar 2019,
MIRAGEN THERAPEUTICS INC - COM (MGEN) was held by
49 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
13,240,655 shares.
The largest 10 holders included
Atlas Venture Advisors, Inc., FMR LLC, 683 Capital Management, LLC, BlackRock Inc., Artal Group S.A., VANGUARD GROUP INC, STATE STREET CORP, JPMORGAN CHASE & CO, NORTHERN TRUST CORP, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
49
institutional shareholders reporting positions in this security
for the Q1 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.